Yahoo! Finance: MYGN News

Restarting Myriad Genetics (at Seeking Alpha)

Thu, 24 Dec 2009 11:56:36 Etc/GMT

Which Is the Best Bet: Biogen, Cepheid, or Myriad? (at Motley Fool)

Wed, 23 Dec 2009 19:09:11 Etc/GMT

Stocks Worth Waiting For (at Motley Fool)

Tue, 22 Dec 2009 21:11:55 Etc/GMT

UPDATE - Myriad Pharma to buy Javelin Pharma for $96 mln (at Reuters)

Fri, 18 Dec 2009 16:31:33 Etc/GMT

Myriad Genetics to Present at the 28th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)

Thu, 17 Dec 2009 21:05:00 Etc/GMT

Myriad Genetics Upgraded to Neutral (Zacks.com)

Thu, 17 Dec 2009 16:26:19 Etc/GMT

Do Gene Sequences Deserve Patent Protection? (at The Wall Street Journal Online)

Thu, 10 Dec 2009 14:01:21 Etc/GMT

Dream Stocks for Biotech Investors (at Motley Fool)

Wed, 25 Nov 2009 20:27:20 Etc/GMT

Heinz Lays It On Rich And Thick (at Forbes.com)

Wed, 25 Nov 2009 00:30:00 Etc/GMT

Myriad Genetics to Present at the 21st Annual Piper Jaffray Health Care Conference (GlobeNewswire)

Tue, 17 Nov 2009 21:05:00 Etc/GMT

Zacks Bull and Bear of the Day Highlights: Infosys, Myriad Genetics Inc., American International Group, Citigroup, Bank of America (Zacks.com)

Mon, 16 Nov 2009 13:47:04 Etc/GMT

Zacks Bull and Bear of the Day Highlights: Infosys, Myriad Genetics Inc., American International Group, Citigroup, Bank of America

Myriad Genetics (MYGN) (Zacks.com)

Mon, 16 Nov 2009 06:00:00 Etc/GMT

J.C. Penney, Disney, Genzyme are big movers (AP)

Fri, 13 Nov 2009 22:10:27 Etc/GMT

The following stocks were among those that moved substantially or traded heavily Friday on the New York Stock Exchange: NYSE:

Piper Jaffray Sees Pharma M&A Activity Continuing (Wall Street Transcript)

Fri, 13 Nov 2009 13:50:00 Etc/GMT

67 WALL STREET, New York - November 13, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Myriad Pharma posts smaller 1Q loss after spinoff (AP)

Fri, 13 Nov 2009 11:54:43 Etc/GMT

Myriad Pharmaceuticals Inc. on Friday reported a smaller fiscal first-quarter loss on lower research costs after the company was spun off from Myriad Genetics Inc.

Myriad Genetics upgraded by Morgan Joseph (Briefing.com)

Wed, 11 Nov 2009 12:31:08 Etc/GMT

3 Stocks Hitting Low Notes (at Motley Fool)

Mon, 9 Nov 2009 18:41:47 Etc/GMT

MYRIAD GENETICS INC Financials (EDGAR Online Financials)

Sat, 7 Nov 2009 14:04:19 Etc/GMT

MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online)

Fri, 6 Nov 2009 15:27:06 Etc/GMT

Myriad Misses by a Penny (Zacks.com)

Fri, 6 Nov 2009 15:26:12 Etc/GMT